Researchers from St. Jude Children’s Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study, which will be published March 7 in the Journal of Experimental Medicine, suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.
According to the World Health Organization, 360 million people worldwide, including 32 million children, suffer from hearing loss caused by congenital defects or other factors. These factors include infectious disease, use of certain medicines, or exposure to excessive noise. Yet, there are currently no FDA-approved drugs to prevent or treat hearing loss.
A team of researchers led by Dr. Jian Zuo screened over 4,000 drugs for their ability to protect cochlear cells from the chemotherapy agent cisplatin. Cisplatin is used to treat a variety of cancers but causes irreversible hearing loss in up to 70% of patients.
Zuo and colleagues identified multiple compounds that protected cochlear cells from cisplatin, several of which are already approved to treat other conditions. Three of the ten most effective compounds were inhibitors of an enzyme called CDK2. One of these CDK2 inhibitors, kenpaullone, was more effective than four other compounds that are currently in clinical trials for treating hearing loss.
Injecting kenpaullone into the middle ear protected both mice and rats from cisplatin-induced hearing loss. Moreover, kenpaullone also protected the hearing of mice to noise as loud as 100 dB. “Given that 100-dB noise is in the range of noise insults commonly experienced by people in our society, kenpaullone could have significant clinical application in treating noise-induced hearing loss,” says Zuo.
In the case of cisplatin-induced hearing loss, kenpaullone appears to protect hair cells by preventing CDK2 from stimulating the production of toxic reactive oxygen species from the cells’ mitochondria.
“The robust protection conferred by one-time local delivery of kenpaullone suggests that CDK2 inhibitors may transform the clinical prevention and treatment of cisplatin- and noise-induced hearing loss in patients,” Zuo says. “Modifications of the treatment regimens, additional optimization of the delivery methods via the use of hydrogels, and structural modifications of the compounds via medicinal chemistry could ensure even better results with CDK2 inhibitors in treating hearing loss in humans.”
The Latest on: Hearing loss
- Too loud for too long: Hearing loss could be a side effect for younger generations who pair loud volume, headphones on November 11, 2018 at 11:10 pm
In today’s age of gaming and devices, headphones are an everyday part of the lives of the younger generations. And while headphones are used mostly to enhance a fun experience, whether it’s listening ... […]
- The connection between diabetes and hearing loss on November 11, 2018 at 10:09 pm
More than 30 million Americans have diabetes — if you're one of them, take note. You may want to keep a close watch on your hearing, too. Research indicates diabetics are more than twice as likely to ... […]
- Untreated Hearing Loss Linked to Increased Hospitalization Risk on November 11, 2018 at 4:29 am
Untreated hearing loss in adults was linked to more hospitalizations, increased risk of 30-day hospital readmission, increased risk of emergency department visits and longer hospital stays, found rese... […]
- Veterans' hearing loss symptoms might not arise until decades later on November 9, 2018 at 2:10 pm
WEBVTT JENNIFER: HERBERT ROGERS IS ONE OF THE FIRST FACES YOU SEE AT THE HEARING AND SPEECH AGENCY OR HASA IN NORTHWEST BALTIMORE. HE WORKS SECURITY HERE BUT ABOUT 15 YEARS AGO HE ALSO BECAME A CLIENT ... […]
- Child's Voice Raises Over $115,000 at Autumn Gala for Children with Hearing Loss on November 9, 2018 at 12:30 pm
What a night! On November 3, 2018, Child's Voice hosted its annual Autumn Gala at the Westin Lombard Yorktown Center and raised over $115,000 to benefit its programs and services! Those in attendance ... […]
- Child's Voice Raises $115,000 for Children with Hearing Loss on November 9, 2018 at 11:26 am
This post was contributed by a community member. What a night! On November 3, 2018, Child's Voice hosted its annual Autumn Gala at the Westin Lombard Yorktown Center and raised over $115,000 to ... […]
- Has this study found a new possible solution for hearing loss? on November 9, 2018 at 7:58 am
Hearing loss affects many people of all age groups and demographics around the world. Whether hearing loss is moderate or severe, people who struggle to hear can experience social isolation ... […]
- Adults with untreated hearing loss suffer more health problems, increased costs: Study on November 8, 2018 at 11:40 am
Older adults with untreated hearing loss spend tens of thousands of dollars on extra medical bills because of longer and more frequent hospital visits, according to research published Thursday. An est... […]
- Untreated Hearing Loss Can Be Costly for Seniors on November 8, 2018 at 9:04 am
THURSDAY, Nov. 8, 2018 (HealthDay News) -- Having hearing loss and not knowing it might translate into higher medical bills and other health problems for many seniors, two new studies suggest. In one ... […]
- Patients with untreated hearing loss incur higher health care costs over time on November 8, 2018 at 8:01 am
Older adults with untreated hearing loss incur substantially higher total health care costs compared to those who don't have hearing loss—an average of 46 percent, totaling $22,434 per person ... […]
via Google News and Bing News